US Stock MarketDetailed Quotes

ANRO Alto Neuroscience

Watchlist
  • 2.500
  • -0.030-1.19%
Close Mar 26 16:00 ET
67.68MMarket Cap-1.10P/E (TTM)

About Alto Neuroscience Company

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Company Profile

SymbolANRO
Company NameAlto Neuroscience
Listing DateFeb 2, 2024
Issue Price16.00
Founded2019
CEODr. Amit Etkin, M.D.
MarketNYSE
Employees76
Fiscal Year Ends12-31
Address650 Castro Street,Suite 450
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94041
Phone1-650-200-0412
Websitehttp://www.altoneuroscience.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Amit Etkin, M.D.
  • President, Chief Executive Officer and Chairman of the Board
  • 1.86M
  • Nicholas Conrad Smith
  • Chief Business Officer, Chief Financial Officer and Principal Accounting Officer
  • 1.60M
  • Michael Conick Hanley, Jr
  • Chief Operating Officer
  • --
  • Adam Savitz
  • Chief Medical Officer
  • 1.24M
  • Dr. Po Yu Chen, PhD
  • Independent Director
  • --
  • Andrew Dreyfus
  • Independent Director
  • 107.37K
  • Gwill York
  • Independent Director
  • 53.68K
  • Mahalakshmi Radhakrishnan, M.D.
  • Independent Director
  • --
  • Christopher Nixon Cox
  • Independent Director
  • --
  • Dr. Husseini Manji
  • Independent Director
  • --

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Zhejiang Huayuan Auto Technology
301535
+389.02%
Zhejiang Huaye Plastics Machinery
301616
+149.11%
SANWEI CO.,LTD.
831834
+29.96%
4
THEC
833509
+21.07%
5
Huarong Chemical
301256
+20.02%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings